EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1) (C-Term) Peptid
EPM2AIP1
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle EPM2AIP1 Produkte
- EPM2AIP1 (EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
- Protein Region
- C-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- EKAFSYLTRN QHTLSQPLTD EHLQALFRVA TTEMEPGWDD LVRERNESNP
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- EPM2AIP1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EPM2AIP1 (EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
- Hintergrund
-
The EPM2A gene, which encodes laforin, is mutated in an autosomal recessive form of adolescent progressive myoclonus epilepsy. The protein encoded by this gene binds to laforin, but its function is not known. This gene is intronless.
Protein Size: 607 - Gen-ID
- 9852
- NCBI Accession
- NM_014805, NP_055620
- UniProt
- Q7L775
-
Sie sind hier:
